Drupal.behaviors.print = function(context) {window.print();window.close();}>
NeoGenomics Moves to Nasdaq Capital Market
December 06, 2012
NeoGenomics Moves to Nasdaq Capital Market
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Rosetta Genomics Warned by Nasdaq on Second Listing Compliance Issue
April 23, 2012 / GenomeWeb Daily News
Nasdaq Extends Deadline for CombiMatrix to Meet Listing Requirement
May 30, 2013 / GenomeWeb Daily News
BG Medicine Fails to Meet Listing Requirement, Nasdaq Warns Firm
May 20, 2013 / GenomeWeb Daily News
Cancer Test Firm NeoGenomics Reports Q1 Revenues up 3 Percent
April 25, 2013 / GenomeWeb Daily News
CombiMatrix Falls Short of Nasdaq Listing Rule Related to Stockholders' Equity
March 12, 2013 / GenomeWeb Daily News